CARPRIEVE 20 MG TABLETS FOR DOGS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

CARPROFEN

Available from:

NORBROOK LABORATORIES AUSTRALIA PTY LIMITED

INN (International Name):

carprofen(20mg/Tb)

Pharmaceutical form:

ORAL TABLET

Composition:

CARPROFEN ANTI-INFLAMMATORY-NONSTEROIDAL Active 20.0 mg/Tb

Units in package:

#100 bl.pk; #10x10; *500 bl.pk; *50x10; 100 tabs; 500 tabs

Class:

VM - Veterinary Medicine

Therapeutic group:

DOG | BITCH | CASTRATE | PUPPY

Therapeutic area:

MUSCULOSKELETAL SYSTEM

Therapeutic indications:

ANTI-INFLAMMATORY AGENT | ANTIPYRETIC | BONE SORENESS | BRUISING | BURSITIS | INFLAMMATORY RHEUMATIC ARTHRIT | JOINT DISEASE | LIGAMENT SPRAINS | MUSCLE SORENESS | OSTEOARTHRITIS | PLATELET ACTIVITY | RHEUMATISM | SPRAINS | STRAINS | TENDON SPRAINS | TRAUMATIC SWELLING

Product summary:

Poison schedule: 4; Withholding period: WHP: N/A.; Host/pest details: DOG: [ANTI-INFLAMMATORY AGENT]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [ANTI-INFLAMMATORY AGENT]; A non steroidal anti-inflammatory drug for the relief of pain and inflammation in dogs.DO NOT use in cats - see Contraindications/Precautions on label.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

Carprieve 20mg
100 Tablet Label
Label file name: 54885_
44397
_1
OOT
_immediate_MPL_
V1.pdf
100%
Actual1:1
Size=
33 x
89mm
(100%
when
printed
on
A4
paper)
12/6/08
APPROVED
LABEL
Info
PEST


Verified
Carprieve 20mg
500 Tablet Label
Label
file
name: 54885_
44397
_SOOT
_immediate_MPL_
V1.pdf
100%
Actual1:1
Size=
49 x 131.75mm
(100%
when
printed
on
A4
paper)
12/6/08
READ
THE
ENCLOSED
LEAFLET
IIIIIIISi
BEFORE
USING
THIS
PRODUCT
DIRECTIONS
FOR
USE
Dosage:
2-4
mg/kg
bodyweight
per
day
.
Dose,
frequency
and
duration
of
treatment
will
be
dependent
upon
clinical
response.
See
leaflet
for
full
details.
Store
below
25°C
(Air
conditioning)
in
a
dry
place
out
of
direct
sunlight.
~---------------J
~~
~
Norbrooli
~
APPROVED
LABEL
Carprieve
20mg
100 x
Blister
Carton
Label
file
name: 54885_44397_100B_primary_MPL_V1.pdf
100%
Actual1:1
Size=
55
x
40
x
130mm
CARPRIEVE
20
mg
Tablets
For
Dogs
(66%
when
printed
on
A4
and
100%
when
printed
on
A3
paper)
1216/08
I
l
lo
1.-:1
.
;
:I
'II
'
I
I' I'
•
::io,;::J.[
"iiT
3'1
.
.
·:I
lllLJ..I·
.
''
. "
-
.
.
'.!I
'if
~·Hn
i'.Wcil
CARPRIEVE
20
mg
Tablets
For
Dogs
_(T _
NORBROOLI
~
ill!
CARPRIEVE
20
mg Tablets
For
Dogs
'·
••.
"1.1!.1;'.
"'1l.l..'
·~
.
,,
• • •
•
•
•
'
•
1')
·~
4 I
:,
I
I
APPROVED
LABEL
CARPRIEVE
20
MG
TABLETS
FOR
DOGS
I...:
,
~I
r;
, ,
::11
UJ::J·
, ,
;lrT"'
,
,
"I
·"7
""'I-;],
l'O:l
UJ·
'
''
"'
'
'
'
'
.
'';,]
-:..L
:ii '
'
~
'
'
1£
.
-
I
I
~
,flfi\f•~r~
''I
I··
I
I
•
I
I~
I
l=T
'
"
'
'
' '
'
.
'
\1
"I'
J
,
"Ji
Carprieve 20mg
500 x Blister Carton
Label
file
name: 54885_
44397
_500B_primary
_MPL_
V1.pdf
100%
Actual1
:1
Size=
205
x
56.5
x
135mm
(50%
when
printed
on
A4
and
74%
when
printed on A3 paper)
12/6/08
CARPRIEVE
20
MG
TABLETS
FOR
DOGS
Norbrooll~
(!)
...........
'
Batch:
Expiry;
APPROVED
LABEL
Carprieve 20mg
Blister Foil
Label file name: 54885_44397_20mg_immediate_MPL_V1.pdf
100% Actual1:1
Size=
50
x 124mm
(1
00%
when
printed on
A4
paper)
12/6/08
FOIIAIIIIAL:E1
_
ENTOIIY
I
FOIIAIIIIAI.EOIU
I
RJRAIIIW.
~
EOIILY
RJRAIIIW.
~TIEIITOIILY
I
FOIIAI

Summary of Product characteristics

PRODUCT NAME: CARPRIEVE TABLETS FOR DOGS
PAGE: 1 OF 4
THIS REVISION ISSUED: JANUARY, 2010
MATERIAL SAFETY DATA SHEET
Issued by: Norbrook Laboratories Australia Pty Ltd
Freecall: 1800 665 866
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
NORBROOK LABORATORIES AUSTRALIA PTY LTD
FREECALL: 1800 665 866
UNIT 7/1 TRADE PARK DRIVE
TULLAMARINE, VIC 3043 AUSTRALIA
SUBSTANCE:
Non-steroidal anti-inflammatory drug in a suitable carrier.
TRADE NAME:
CARPRIEVE TABLETS FOR DOGS
APVMA CODES:
54885 (20mg/tab) & 54884 (50mg/tab) & 63022 (100mg/tab) Three products
with
different levels of active.
PRODUCT USE:
A non-steroidal anti-inflammatory drug for the relief of pain and
inflammation in dogs.
CREATION DATE:
JUNE, 2009
THIS VERSION ISSUED:
JANUARY, 2010
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of ASCC.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S22, S25. Do not breathe dust. Avoid contact with eyes.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: A white to off-white circular tablet.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. This is
a physiologically active
product and so contact should be minimised, especially if the user is
taking a form of medication, as interactions can
sometimes give unexpected and undesired results.
POTENTIAL HEALTH EFFECTS
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN